Risk Factors and Predictive Analysis of Acute Severe Abdominal Pain After Hepatic Artery Infusion Chemotherapy in Patients with Hepatocellular Carcinoma
Jinpeng Li,1,* Congcong Shi,2,* Jiao Chen,1 Yue Zhao,3 Jiasheng Du,4,* Jinlong Song1 1Department of Interventional Therapy I, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, People’s...
Saved in:
| Main Authors: | Li J, Shi C, Chen J, Zhao Y, Du J, Song J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/risk-factors-and-predictive-analysis-of-acute-severe-abdominal-pain-af-peer-reviewed-fulltext-article-JHC |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements
by: Wei Xu, et al.
Published: (2025-05-01) -
Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma: A Three-Dimensional Visualization Perspective
by: Tan Y, et al.
Published: (2025-04-01) -
Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
by: Zheng X, et al.
Published: (2025-06-01) -
Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
by: Shiguang Chen, et al.
Published: (2025-12-01) -
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
by: Ji Yeon Lee, et al.
Published: (2024-12-01)